Medebound HEALTH Executed Contract with Manulife SinoChem, Reaching 1.8 million Nationwide Members

Updated: Oct 25

Recently, Medebound HEALTH has established a formal contractual relationship with Manulife Life Insurance Co., Ltd in China. (hereinafter referred to as "Manulife Sinochem") and became its overseas medical service partner, providing members of Manulife Sinochem with second diagnosis and treatment opinion from the US top specialists and other overseas medical services.



Medebound HEALTH leaders with the experts from New York-Presbyterian Hospital


Manulife SinoChem and Medebound HEALTH co-hosted a member event in Shanghai



Most recently, MedeboundHEALTH and Manulife Sinochem successfully held the "Zero Distance to U.S. Medical Resources " (Shanghai Station) high-end members event at Raffles City Changning, Shanghai. At the scene, Medebound HEALTH invited Andrea Daquino, director of the International Department of Columbia University New York-Presbyterian Hospital, and Dr. Jason D. Wright, director of the Department of Oncology and Gynecology, Columbia University New York-Presbyterian Hospital. Two American healthcare experts introduced American medical resources, shared academic lectures followed by on-site exchanges and interactions with the members. The marketing director of Medebound HEALTH Mr. Wan also gave a lecture to the audience on how telehealth made it possible for patients in China to access top expertise in the US. Through Medebound HEALTH's cross-border teleconsultation platform, cancer patients in the eastern world can consult US-based cancer specialists with a few clicks, and patients can also easily access advanced medicines via our pharmaceutical logistics system.


Manulife Sinochem is the first Sino-foreign joint venture life insurance company in China. It is a joint venture established by Manulife Insurance (International) Co., Ltd., a subsidiary of Manulife Canada, and Sinochem Finance Co., Ltd., a core member of Sinochem Corporation. Manulife Sinochem was established in November 1996 and now has nearly 16,000 employees and salesmen, providing professional financial and insurance services to more than 1.8 million customers. At present, Manulife Sinochem is developing steadily in more than 50 cities in Shanghai, Beijing, Guangdong, Zhejiang, Jiangsu, Sichuan, Shandong, Fujian, Chongqing, Liaoning, Tianjin, Hubei, Hebei and Hunan, and continues to move towards the whole country. Manulife Sinochem has been operating in the Chinese insurance market for more than 20 years, and is committed to providing the public with stable, reliable, trustworthy, and far-sighted insurance products and services.


Medebound HEALTH (www.medeboundHEALTH.com) is a global telehealth company with the focus on connecting overseas patients/physicians with US doctors and advanced treatment methods and medicines. This is achieved by creating a proprietary bi-lingual HIPAA-compliant telehealth platform, which facilitates secure medical imaging/records translation, transferring and teleconsultations; and by a robust supply chain for advanced medicine. With this highly differentiated physician network and bilingual IT platform and a strong execution team, Medebound has gained significant market traction with customers including major hospital centers and insurers in Asia.


Medebound HEALTH has always been committed to bringing the world's best medical resources into the emerging markets, so that more overseas people can access advanced medical concepts, leading medical technology, and innovative treatments. And at the same time, Medebound HEALTH facilitates virtual collaborative care so difficult clinical cases can be treated locally without the need to travel to the United States.